Begin Learning

Step 1: Week 1

Pre-training

Through a series of online videos, staff and physicians learn about the insertion and removal procedures and how to create a sterile field for the Eversense CGM System. Training is less than 30 minutes.

Watch Video

SETTING UP A STERILE FIELD
This instructional video demonstrates the basic principles of setting up a sterile field...…



Watch Video >
Download PDF

EVERSENSE SENSOR INSERTION 
AND REMOVAL INSTRUCTIONS
Review a step-by-step guide on the sensor procedures.…



Download PDF >
Watch Video

EVERSENSE REIMBURSEMENT FACTS AND STEP-BY-STEP PROCESS



Watch Video >
Watch Video

EVERSENSE PATIENT 
EDUCATION TRAINING



Watch Video >

Step 2: Weeks 2 - 3

In-office Training

In-office training led by a Senseonics District Clinical Manager and District Business Manager.

noun_accept_152964_000000_copy_3_1-3x.png Hands-on training

noun_accept_152964_000000_copy_3_1-3x.png Education on the Eversense technology

noun_accept_152964_000000_copy_3_1-3x.png Defining and identifying technology

noun_accept_152964_000000_copy_3_1-3x.png Introduction of the 3 patients -2 weeks -3 patients (3-2-3)
      mastery methodology

Step 3: Week 2

Patient Identification and scheduling

It is best practice to establish a procedure timeframe and a patient scheduling process within the first 2 weeks.

Establish an initial date for first Eversense insertions

Identify a minimum of 3 additional patients and schedule 2 weeks following initial insertion date (3-2-3);

Identify and schedule a minimum of 3 initial patients

Prepare for first insertions — Order supplies (see Eversense CGM Sensor Insertion and Removal Kit & Equipment List)

Step 4: Week 2

Product Ordering Reimbursement

Senseonics has a number of resources and partners in place to help with online and telephone ordering and reimbursement.

Log in to the Eversense Physician Portal and enter patient and insurance information

LOGIN

 

Contact Customer Order Services at 844-SENSE4U (736-7348), Option 1   CALL NOW >

Step 5: Weeks 3 - 4

Procedure
Day 1

The Senseonics support team will
be onsite to 
provide assistance
on procedure Day 1.

noun_accept_152964_000000_copy_3_1-3x.png  Providing procedure oversight

noun_accept_152964_000000_copy_3_1-3x.png Verifying proper supplies are on hand

noun_accept_152964_000000_copy_3_1-3x.png Inspecting and verifying the room

noun_accept_152964_000000_copy_3_1-3x.png Reviewing and debriefing post-insertions

noun_accept_152964_000000_copy_3_1-3x.png Scheduling removal certification for 
post-90 days

Register For Training

Online Registration Form

Need More Information?

Request Info

Explore All Resources

Learn More

Disclaimer

The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration twice per day, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a Health Care Provider. The Eversense CGM System is a prescription device; patients should talk to their Health Care Provider to learn more. For important safety information, see https://eversensediabetes.com/safety-info/.

Eversense, Eversense Continuous Glucose Monitoring, Eversense CGM, Eversense Sensor, Eversense Smart Transmitter, Eversense App and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.
Other brands and their products are trademarks or registered trademarks of their respective holders.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System.
Android is a trademark of Google LLC.

© 2021 Senseonics, Incorporated. All rights reserved.
© 2021 Ascensia Diabetes Care Holdings AG. All rights reserved.